PMX-27278-03418
3 vaccinations
5 coded responses
36 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 480 / MI
- Registered
- 2021-08-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-14
Dose 1 — Pfizer-BioNTech
-
2021-08-16
Registered in v-safe
- 2021-08-16
- 2021-08-17
- 2021-08-18
- 2021-08-20
- 2021-08-21
- 2021-08-28
-
2021-09-04
Dose 2 — Pfizer-BioNTech
- 2021-09-04
-
2021-09-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-09-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-09-07
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessFree text: Swollen lymph nodesMedDRA releases: 2024-11 · check-in free text available
-
2021-09-08
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen lymph nodesMedDRA releases: 2024-11 · check-in free text available
-
2021-09-09
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Swollen lymph nodesMedDRA releases: 2024-11 · check-in free text available
-
2021-09-10
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen lymph nodesMedDRA releases: 2024-11 · check-in free text available
-
2021-09-11
Survey response — day 7, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen lymph nodesMedDRA releases: 2024-11 · check-in free text available
- 2021-09-18
- 2021-09-25
- 2021-10-02
- 2021-10-09
- 2021-10-16
- 2021-12-04
- 2022-03-05
- 2022-09-05
-
2022-09-24
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-25
- 2022-09-26
- 2022-09-27
- 2022-09-28
- 2022-09-29
- 2022-09-30
- 2022-10-01
- 2022-10-08
- 2022-10-15
- 2022-10-22
- 2022-10-29
- 2022-11-05
- 2022-12-24
- 2023-03-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-14 | Pfizer-BioNTech | No |
| 2 | 2021-09-04 | Pfizer-BioNTech | No |
| 3 | 2022-09-24 | Pfizer-BioNTech | Flu |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymph nodes
Systemic reaction (other): Swollen lymph nodes
Systemic reaction (other): Swollen lymph nodes
Systemic reaction (other): Swollen lymph nodes
Release 9 — day 7, dose 2
Systemic reaction (other): Swollen lymph nodes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release